Platelet-rich fibrin and bovine porous bone mineral vs. platelet-rich fibrin in the treatment of intrabony periodontal defects

Journal of Periodontal Research

Volumn 47, Issue 4, 2012, Pages 409-417

  Lekovic, V ^a,b   Milinkovic, I ^b   Aleksic, Z ^b   Jankovic, S ^b   Stankovic, P ^b   Kenney, E B ^a,b   Camargo, P M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Bovine porous bone mineral; Intrabony defect fill; Periodontal regeneration; Platelet rich fibrin

Indexed keywords

FIBRIN;

ADULT; ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BONE MATRIX; BONE PROSTHESIS; BONE REGENERATION; CATTLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; PERIODONTICS; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; TRANSPLANTATION;

ADULT; ALVEOLAR BONE LOSS; ANIMALS; BLOOD PLATELETS; BONE MATRIX; BONE REGENERATION; BONE SUBSTITUTES; CATTLE; DOUBLE-BLIND METHOD; FEMALE; FIBRIN; HUMANS; MALE; MIDDLE AGED; PERIODONTAL INDEX;

EID: 84862871421     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01446.x     Document Type: Article

References (44)

1. Carranza FA Jr, Takei HH, Cochran DL. Reconstructive periodontal surgery. In: Newman MG, Takei HH, Klokkevold PR, Carranza FA Jr, eds. Carranza's Clinical Periodontology, 10th edn. Philadelphia: Saunders Elsevier, 2006:968-990.
2. Cortellini P, Tonetti MS. Regenerative periodontal therapy. In: Lang NP, Lindhe J, eds. Clinical Periodontology and Implant Dentistry, 5th ed. Copenhagen: Munksgaard, 2008:902-954.
3. Wetzel AZ, Stich H, Caffesse RG. Bone apposition onto oral implants in the sinus area filled with different grafting materials. A histological study in beagle dogs. Clin Oral Implants Res 1995;6:155-163.
4. Camargo PM, Lekovic V, Weinlaender M et al. A controlled re-entry study on the effectiveness of bovine porous bone mineral used in combination with a collagen membrane of porcine origin in the treatment of intrabony defects in humans. J Clin Periodontol 2000;27:889-896.
5. Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Kenney EB. Comparison of platelet-rich plasma, bovine porous bone mineral and guided tissue regeneration against platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study. J Periodontol 2002;73:198-205.
6. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Kenney EB. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res 2002;37:300-306.
7. Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Aleksic Z, Kenney EB. Effectiveness of a combination of platelet-rich plasma, bovine porous bone mineral and guided tissue regeneration in the treatment of mandibular grade II molar furcations in humans. J Clin Periodontol 2003;30:746-751.
8. Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol 2000;71:1110-1116.
9. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Kenney EB, Madzarevic M. The effectiveness of enamel matrix proteins used in combination with bovine porous bone mineral in the treatment of intrabony defects in humans. J Clin Periodontol 2001;28:1016-1022.
10. Camargo PM, Lekovic V, Weinlaender M, Resnik TD, Pavlovic M, Kenney EB. A surgical re-entry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontol 2009;80:915-922.
11. Camelo M, Nevins M, Schenk R et al. Clinical, radiographic, and histologic evaluation of human periodontal defects treated with Bio-Oss and Bio-Gide. Int J Periodontics Restorative Dent 1998;18:321-331.
12. Giannobile WV. The potential role of growth and differentiation factors in periodontal regeneration. J Periodontol 1996;67:545-553.
13. Wang HL, Pappert TD, Castelli WA, Chiego DJJr, Smith BA. The effect of platelet derived growth factor on the cellular response of the periodontium: an autoradiographic study on dogs. J Periodontol 1994;65:429-436.
14. Lynch SE, Williams RC, Polson AM et al. A combination of platelet-derived growth factor and insulin-like growth factor enhances periodontal regeneration. J Clin Periodontol 1989;16:545-548.
15. Lynch SE, de Castilla GR, Wiliams RC et al. The effects of short-term application of a combination of platelet derived and insulin-like growth factors on periodontal wound healing. J Periodontol 1991;62:458-467.
16. Giannobile WV, Finkelman RD, Lynch SE. Comparison of canine and non-human primate animal models for periodontal regenerative therapy. Results following a single administration of PDGF/IGF-I. J Periodontol 1994;65:1158-1168.
17. Rutherford RB, Niekrash CE, Kennedy JE, Charette MF. Platelet-derived and insulin-like growth factors stimulate periodontal attachment in monkeys. J Periodontal Res 1992;27:285-290.
18. Rutherford RB, Ryan ME, Kennedy JE, Tucker MM, Charette MF. Platelet-derived growth factor and dexamethasone combined with a collagen matrix induce regeneration of the periodontium in monkeys. J Clin Periodontol 1993;20:537-544.
19. Sigurdsson TJ, Lee MB, Kubota K, Turek TJ, Wozney JM, Wikesjo UM. Periodontal repair in dogs: recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J Periodontol 1995;66:131-138.
20. Ripamonti U, Heliotis M, van den Heever B, Reddi AH. Bone morphogenetic proteins induce periodontal regeneration in the baboon (Papio ursinus). J Periodontal Res 1994;29:439-445.
21. Sigurdsson TJ, Nygaard L, Tatakis DN et al. Periodontal repair in dogs: evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 1996;16:524-537.
22. King GN, King N, Cruchley AT, Wozney JM, Hughes FJ. Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects. J Dent Res 1997;76:1460-1467.
23. Nevins M, Giannobile WV, McGuire MK et al. Platelet derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol 2005;76:2205-2215.
24. Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE. A phase I/II clinical trial to evaluate a combination of recombinant human-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997;68:1186-1193.
25. Choukroun J, Adda F, Schoeffler C, Vervelle A. An opportunity in perio-implantology: the PRF. Implantodontie 2001;42:55-62.
26. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leukocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009;27:158-167.
27. Dohan DM, Choukroun J, Diss A et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:45-50.
28. Dohan DM, Choukroun J, Diss A et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leukocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:51-55.
29. Dohan Ehrenfest DM, Del Corso M, Diss A, Mouhyi J, Charrier JP. Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane. J Periodontol 2010;81:546-555.
30. Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009;27:63-69.
31. Jankovic S, Aleksic Z, Milinkovic I, Dimitrijevic B. The coronally advanced flap in combination with platelet-rich fibrin (PRF) and enamel matrix derivative in the treatment of gingival recession: a comparative study. Eur J Esthet Dent 2010;5:260-273.
32. Aroca S, Keglevich T, Barbieri B, Gera I, Etienne D. Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study. J Periodontol 2009;80:244-252.
33. Pradeep AR, Sharma A. Autologous platelet rich fibrin in the treatment of mandibular degree II furcation defects: a Randomized Clinical Trial. J Periodontol 2011;82:1396-1403.
34. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
35. Mühlemann HR, Son S. Gingival sulcus bleeding - A leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107-113.
36. Landry RG, Turnbull RS, Howley T. Effectiveness of benzydamine HCL in the treatment of periodontal post-surgical patients. Res Clin Forums 1988;10:105-118.
37. Dohan DM. Platelet-rich fibrin (PRF): a second-generation platelet concentration. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:37-44.
38. Cieslik-Bielecka A, Gazdzik TS, Bielecki TM et al. Why the platelet-rich gel has antimicrobial activity? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:303-305.
39. Werther K, Christensen IJ, Nielsen HJ. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest 2002;62:343-350.
40. Choukroun J, Diss A, Simonpieri A et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:56-60.
41. Waerhaug J. Healing of the dento-epithelial junction following subgingival plaque control. II: as observed on extracted teeth. J Periodontol 1978;49:119-134.
42. Lekovic V, Camargo PM, Weinlaender M, Kenney EB, Vasilic N. Combination use of bovine porous bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans. J Periodontol 2001;72:583-589.
43. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Madzarevic M, Kenney EB. A reentry study on the use of bovine porous bone mineral, GTR, and platelet-rich plasma in the regenerative treatment of intrabony defects in humans. Int J Periodontics Restorative Dent 2005;25:49-59.
44. Döri F, Kovács V, Arweiler NB et al. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study. J Periodontol 2009;80:1599-1605.